TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
RMTI

Rockwell Medical Inc

Healthcare · Drug Manufacturers - Specialty & Generic

8.40$ -2.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement RMTI
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +2.1% -3.7% +7.5% +10.6% -3.3% +1.5% -0.4% +17.6% +14.8% +21.4% -31.8%
– +1.7% +0.3% +15.2% +21.2% -10.0% +1.7% +8.2% +6.8% +9.0% +12.1% -31.5%
– +4.6% -24.5% -45.2% -142.8% – -4.0% -188.8% – +113.5% +100.9% -33.1%
– -36.3% +17.7% +8.2% +6.7% +2.1% +3.0% -3.6% -54.4% -64.5% -98.3% -100.0%
– +4.1% +10.7% +10.3% -5.3% -4.9% -22.9% -5.2% +1.9% -22.4% +16.2% +99,361.3%
– -7.9% +12.2% +9.9% +0.7% +23.8% -15.7% -10.4% -25.3% -26.3% +9.8% -2.9%
– – – – – – – – – – – -871.5%
– +363,433.7% +33.8% +28.3% -100.0% – – +25.6% -18.0% +18.9% -45.5% -10.4%
– – – – – – – – – – – –
– -100.0% – -100.4% – -1,073.5% – +126.5% -19.5% -32.8% – –
– – – – – – – – – – – –
– – – – – – – – – – – -167.6%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?